Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle stem cells are a promising source for tissue repair and treating skin or hair diseases.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Gene therapy in mice increased lifespan and improved health without causing cancer.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

Gene therapy with the Math1 gene helped regenerate balance-related cells and improve balance in mice.

New materials and methods could improve skin healing and reduce scarring.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Applying a special DNA plasmid to the skin can make it thicker and stronger.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Scientists turned mouse stem cells into skin cells that can grow into skin layers and structures.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

Inducing survivin in normal tissues can protect against radiation damage.

Activating the Sonic hedgehog gene in mice can start the hair growth phase.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Hair follicles could be used to deliver drugs effectively, with the right understanding and methods.